AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

OLANZAPINE 10 Mg ;

11 registrations across 1 African market— 11 active

Markets with OLANZAPINE 10 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Olanvexa 10 mg
orally disintegrating Tablets
🇪🇬EgyptMulticare Egypt for Pharmaceutical Industriesactive
Ranxapin 10 mg
Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Olanvexa 10 mg
orally disintegrating Tablets
🇪🇬EgyptMulticare Egypt for Pharmaceutical Industriesactive
Prexal 10 mg
Film Coated Tablets
🇪🇬EgyptRomex Pharmaceuticalactive
Bioprex 10 mg
Film coated caplets
🇪🇬EgyptCLAVITA PHARMAactive
Olazorix 10mg
Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Prexal 10 mg
Film Coated Tablets
🇪🇬EgyptRomex Pharmaceuticalactive
Bioprex 10 mg
Film coated caplets
🇪🇬EgyptCLAVITA PHARMAactive
Zyprexa Velotab
Oro-dispersible tablet
🇪🇬EgyptOnco pharm Egyptactive
Olazorix 10mg
Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Ranxapin 10 mg
Tablets
🇪🇬EgyptSun pharma Egypt limitedactive

OLANZAPINE 10 Mg ; in Africa — Regulatory Overview

OLANZAPINE 10 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.